HomeCompareSOLTF vs QSR

SOLTF vs QSR: Dividend Comparison 2026

SOLTF yields 37.88% · QSR yields 3.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SOLTF wins by $181.7K in total portfolio value
10 years
SOLTF
SOLTF
● Live price
37.88%
Share price
$5.28
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$206.4K
Annual income
$33,329.74
Full SOLTF calculator →
QSR
QSR
● Live price
3.40%
Share price
$73.76
Annual div
$2.51
5Y div CAGR
-0.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.7K
Annual income
$387.88
Full QSR calculator →

Portfolio growth — SOLTF vs QSR

📍 SOLTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSOLTFQSR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SOLTF + QSR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SOLTF pays
QSR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SOLTF
Annual income on $10K today (after 15% tax)
$3,219.70/yr
After 10yr DRIP, annual income (after tax)
$28,330.28/yr
QSR
Annual income on $10K today (after 15% tax)
$289.25/yr
After 10yr DRIP, annual income (after tax)
$329.70/yr
At 15% tax rate, SOLTF beats the other by $28,000.58/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SOLTF + QSR for your $10,000?

SOLTF: 50%QSR: 50%
100% QSR50/50100% SOLTF
Portfolio after 10yr
$115.6K
Annual income
$16,858.81/yr
Blended yield
14.59%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on QSR right now

SOLTF
No analyst data
Altman Z
0.7
Piotroski
4/9
QSR
Analyst Ratings
27
Buy
15
Hold
2
Sell
Consensus: Buy
Price Target
$81.57
+10.6% upside vs current
Range: $71.00 — $90.00
Altman Z
1.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SOLTF buys
0
QSR buys
0
No recent congressional trades found for SOLTF or QSR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSOLTFQSR
Forward yield37.88%3.40%
Annual dividend / share$2.00$2.51
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-0.8%
Portfolio after 10y$206.4K$24.7K
Annual income after 10y$33,329.74$387.88
Total dividends collected$152.8K$3.7K
Payment frequencyquarterlyquarterly
SectorStockStock

Year-by-year: SOLTF vs QSR ($10,000, DRIP)

YearSOLTF PortfolioSOLTF Income/yrQSR PortfolioQSR Income/yrGap
1← crossover$14,488$3,787.88$11,038$337.57+$3.5KSOLTF
2$20,631$5,128.82$12,156$345.43+$8.5KSOLTF
3$28,901$6,825.67$13,359$352.69+$15.5KSOLTF
4$39,860$8,936.20$14,654$359.36+$25.2KSOLTF
5$54,169$11,518.54$16,045$365.45+$38.1KSOLTF
6$72,590$14,629.36$17,539$370.97+$55.1KSOLTF
7$95,993$18,321.84$19,143$375.96+$76.8KSOLTF
8$125,356$22,643.78$20,863$380.42+$104.5KSOLTF
9$161,767$27,635.79$22,708$384.39+$139.1KSOLTF
10$206,420$33,329.74$24,685$387.88+$181.7KSOLTF

SOLTF vs QSR: Complete Analysis 2026

SOLTFStock

Nxera Pharma Co., Ltd. develops and sells biopharmaceutical products in Japan, Switzerland, the United States, Bermuda, and the United Kingdom. Its product portfolio products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair and Breezhaler for the treatment of asthma; ORAVI, a novel formulation for the treatment of oropharyngeal candidiasis; and PIVLAZ for the treatment of cerebral vasospasm indications. The company's development products pipeline consists of HTL0039732 for immuno-oncology indications; HTL0048149 for schizophrenia disorders; Daridorexant for the treatment of insomnia; HTL0016878 for schizophrenia and other neuropsychiatric disorders; PF-07081532 for Type 2 diabetes mellitus and obesity; PF-07054894 for inflammatory bowel disease; PF-07258669 for anorexia; PF-06954522 for metabolic diseases; NBI-1117569 for neurology diseases; and NBI-1117570 for central nervous system (CNS) disorders. It is also involved in the development of GPR35 agonist, for inflammatory bowel disease/GI disorders, which is in preclinical stage; and other discovery and preclinical stage drugs. Nxera Pharma Co., Ltd. has a strategic collaboration with AbbVie, Biohaven, Genentech Inc., GSK, Pfizer Inc., Neurocrine Biosciences Inc., Novartis International AG, and Verily. Nxera Pharma Co., Ltd. was incorporated in 1990 and is headquartered in Tokyo, Japan.

Full SOLTF Calculator →

QSRStock

Restaurant Brands International Inc. operates as quick service restaurant company in Canada and internationally. It operates through four segments: Tim Hortons (TH), Burger King (BK), Popeyes Louisiana Kitchen (PLK), and Firehouse Subs (FHS). The company owns and franchises TH chain of donut/coffee/tea restaurants that offer blend coffee, tea, and espresso-based hot and cold specialty drinks; and fresh baked goods, including donuts, Timbits, bagels, muffins, cookies and pastries, grilled paninis, classic sandwiches, wraps, soups, and others. It is also involved in owning and franchising BK, a fast food hamburger restaurant chain, which offers flame-grilled hamburgers, chicken and other specialty sandwiches, french fries, soft drinks, and other food items; and PLK quick service restaurants that provide Louisiana style fried chicken, chicken tenders, fried shrimp and other seafood, red beans and rice, and other regional items. In addition, the company owns and franchises FHS restaurants quick service restaurants that offer subs, soft drinks, and local specialties. As of February 15, 2022, the company had approximately 29,000 restaurants in 100 countries under the Tim Hortons, Burger King, Popeyes, And Firehouse Subs brands. Restaurant Brands International Inc. was founded in 1954 and is headquartered in Toronto, Canada.

Full QSR Calculator →
📬

Get this SOLTF vs QSR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SOLTF vs SCHDSOLTF vs JEPISOLTF vs OSOLTF vs KOSOLTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.